Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity

Alnylam Pharma (ALNY) Tops Q4 EPS by 16c

February 11, 2021 8:03 AM EST

Alnylam Pharma (NASDAQ: ALNY) reported Q4 EPS of ($1.60), $0.16 better than the analyst estimate of ($1.76). Revenue for the quarter came in at $163.6 million versus the consensus estimate of $146.07 million.

Provides 2021 Combined Net Product Revenue Guidance of $610-660 Million, in addition to Collaboration & Royalty Revenue and... More